Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Therachon
Biotech
Gene therapy player InnoSkel debuts with €20M
Elvire Gouze Ph.D., a serial entrepreneur and expert in skeletal disorders, has formed another company—InnoSkel.
Phil Taylor
Dec 14, 2020 8:50am
Pfizer offers $340M upfront to buy Therachon for dwarfism drug
May 8, 2019 8:14am
Rare disease startup Therachon nets GLyPharma and its SBS drug
Oct 9, 2018 10:23am
Novo powers rare disease startup Therachon to $60M round
Aug 9, 2018 10:35am
Chutes & Ladders—Andrew Witty shifts to PBM as Optum's CEO
Mar 16, 2018 4:02am
Chutes & Ladders—Sanofi’s diabetes and CV head to helm Almirall
Aug 31, 2017 3:56pm
